ロード中...
Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)
OBJECTIVE: It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on cardiovascular outcomes varied by different LDL-cholesterol levels at baseline in EMPA-REG OUTCOME. METHOD...
保存先:
| 出版年: | Diab Vasc Dis Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7919220/ https://ncbi.nlm.nih.gov/pubmed/33307785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164120975256 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|